超低剂量成像对光子计数探测器CT不同亚型肺结节图像质量与体积准确性的影响:体模研究
该体模研究评估超高清光子计数探测器CT(UHR PCD-CT)在5个剂量水平下对15个肺结节模型的检出率、图像质量及直径/体积测量准确性的影响。结果表明,剂量降低会显著降低结节检出率并增加直径与体积的绝对百分比误差,实性结节及≥6 mm结节表现更优。即使在0.03-0.50 mGy超低剂量下,UHR PCD-CT联合AI辅助诊断软件仍能维持结节检出并提供诊断级图像。
要点
- 超低剂量(0.03-0.50 mGy)下UHR PCD-CT仍可检出肺结节并提供诊断级图像。
- 实性结节检出率优于磨玻璃结节,≥6 mm结节优于更小结节。
- 剂量降低会降低检出率并增大直径与体积测量误差。
核心结论
- 在0.03-0.50 mGy超低剂量条件下,UHR PCD-CT联合AI辅助诊断软件仍能维持肺结节检出并提供诊断级图像。
- 剂量降低会显著降低肺结节检出率并增加直径与体积测量的绝对百分比误差。
- 实性结节检出性优于磨玻璃结节,≥6 mm结节优于更小结节。
研究设计与样本
- 体模研究,使用含15个肺结节模型的胸部体模,在UHR PCD-CT上以5个剂量水平扫描。
- 定量分析各剂量水平下结节的检出率、长轴/短轴直径、噪声值(SD)、信噪比(SNR)和对比噪声比(CNR)。
- 使用肺结节AI诊断软件测量结节体积并计算体积绝对百分比误差(APEvolume),同时计算直径测量绝对百分比误差(APEdiameter)。
- 主观图像质量采用5分制评估,以1.00 mGy剂量组图像为参考。
诊断标准与关键数值
- 剂量降低显著降低肺结节检出率,并增加APEdiameter和APEvolume。
- 实性结节(SNs)检出性优于磨玻璃结节(GGNs),≥6 mm结节优于更小结节。
- 0.50 mGy组主观图像质量清晰但略差于标准剂量1.00 mGy组(均P < .05)。
临床应用与阅片要点
- 在超低剂量UHR PCD-CT扫描中,可结合AI辅助诊断软件进行肺结节检出与体积测量。
- 阅片时需注意磨玻璃结节及<6 mm结节在超低剂量下检出率及测量准确性可能下降。
- 0.50 mGy图像质量略低于1.00 mGy标准剂量,报告时应考虑剂量对图像质量的影响。
局限性
- 本研究为体模研究,结果需在临床患者中进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the impact of ultra-high-resolution photon-counting detector CT (UHR PCD-CT) combined with ultra-low dose scanning protocol on the detection rate, image quality, diameter, and volumetric measurement accuracy of pulmonary nodules of varying sizes and types.
METHODS: A thoracic phantom with 15 pulmonary nodule models was scanned on UHR PCD-CT at 5 dose levels. Quantitative analysis was performed on the detection rate, long-axis/short-axis diameters, noise value (SD), signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR) of the nodules at each dose level. Pulmonary nodule AI diagnostic software was used to measure nodule volume and calculate the absolute percentage error in volume (APEvolume). Similarly, the absolute percentage error in diameter measurement (APEdiameter) was calculated. Subjective image quality was assessed using a 5-point scale, with images from the 1.00 mGy dose group as the reference.
RESULTS: Dose reduction significantly lowered the detection rates of pulmonary nodules while increasing both APEdiameter and APEvolume. Solid nodules (SNs) exhibited better detectability compared to ground-glass nodules (GGNs), with nodules ≥6 mm showing superior performance over smaller lesions. Subjectively, performance at 0.50 mGy was clear but slightly worse than that at standard-dose (1.00 mGy) (all P < .05).
CONCLUSIONS: Even under ultra-low dose conditions (0.03-0.50 mGy), UHR PCD-CT combined with AI-assisted diagnostic software can still maintain the detection of pulmonary nodules and provide diagnostic-quality images.
ADVANCES IN KNOWLEDGE: UHR PCD-CT is capable of yielding diagnostic image quality even at significantly reduced radiation doses, allowing for the confident assessment of specific nodule types and larger nodules.
引用
- Wang Y, Zhou Y, Lei L, et al. Impact of ultra-low-dose imaging on image quality and volumetric accuracy of different subtypes of pulmonary nodules using photon-counting detector CT: a phantom study. Br J Radiol. 2026. PMID: 42191650. doi:10.1093/bjr/tqag127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。